Latest Articles
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer Pharmacy Times
Published: Feb. 10, 2025, 2:34 p.m.
Contraceptive Pill Could Help Reduce Risk Of Ovarian Cancer, Study Suggests - Sepoy.net
Contraceptive Pill Could Help Reduce Risk Of Ovarian Cancer, Study Suggests Sepoy.net
Published: Feb. 10, 2025, 7:18 a.m.
FDA Grants Breakthrough Status to Endometrial Cancer Assay - www.oncnursingnews.com/
FDA Grants Breakthrough Status to Endometrial Cancer Assay www.oncnursingnews.com/
Published: Feb. 9, 2025, 3:01 p.m.
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer - Nature.com
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer Nature.com
Published: Feb. 8, 2025, 1:17 p.m.
Long-term risk of endometrial cancer after assisted reproductive technology.
What is the risk of endometrial cancer after long-term follow-up in women treated with ART between 1983 and 2001 compared with women in the general population and subfertile women who …
Published: Feb. 7, 2025, midnight
Rectal Endometriosis-Associated Adenocarcinoma: A Rare Entity Demanding Clinical Vigilance.
Endometriosis may become malignant, and its diagnosis is challenging, especially in rare extra-ovarian sites like the rectum. Here, we describe the case of a 42-year-old woman who presented with intermittent …
Published: Feb. 7, 2025, midnight
Uterine cancer has been impacting more Black women: Here's what to look out for - NBC Miami
Uterine cancer has been impacting more Black women: Here's what to look out for NBC Miami
Published: Feb. 6, 2025, 11:12 p.m.
GLP1R Modulates Ferroptosis and Promotes Endometrial Cancer Progression: Insights from AN3CA Cell Study - Medical Dialogues
GLP1R Modulates Ferroptosis and Promotes Endometrial Cancer Progression: Insights from AN3CA Cell Study Medical Dialogues
Published: Feb. 6, 2025, 2:45 p.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Medical Device Network
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Medical Device Network
Published: Feb. 6, 2025, 10 a.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Yahoo! Voices
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Yahoo! Voices
Published: Feb. 6, 2025, 9:54 a.m.
Link copied to clipboard!